Mesenchymal Stem Cells and Pericytes: To What Extent Are They Related?

Stem Cells and Development

Volumn 25, Issue 24, 2016, Pages 1843-1852

  De Souza, Lucas Eduardo Botelho ^a,b   Malta, Tathiane Maistro ^a,b   Kashima Haddad, Simone ^b   Covas, Dimas Tadeu ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b National Institute of Science and Technology in Stem Cell and Cell Therapy   (Brazil)

Author keywords

adventitial cells; Mesenchymal stem cell; niche; pericytes; tissue specific stem cells

Indexed keywords

CELL MARKER; MOLECULAR MARKER;

BLOOD VESSEL WALL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRAVASCULAR SPACE; HOMEOSTASIS; HUMAN; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOLECULAR EVOLUTION; NONHUMAN; PERICYTE; PERIVASCULAR SPACE; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STROMA CELL; ANIMAL; BONE; CYTOLOGY; MESENCHYMAL STROMA CELL;

ANIMALS; BONE AND BONES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MESENCHYMAL STROMAL CELLS; PERICYTES;

EID: 85004115629     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2016.0109     Document Type: Review

References (99)

1. Bianco P, X Cao, PS Frenette, JJ Mao, PG Robey, PJ Simmons and C-Y Wang. (2013). The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19:35-42.
2. Trounson A and C McDonald. (2015). Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17:11-22.
3. Tavassoli M and WH Crosby. (1968). Transplantation of marrow to extramedullary sites. Science 161:54-56.
4. Friedenstein AJ, RK Chailakhjan and KS Lalykina. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
5. Friedenstein AJ, RK Chailakhyan, NV Latsinik, AF Panasyuk and IV Keiliss-Borok. (1974). Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331-340.
6. Friedenstein AJ, RK Chailakhyan and UV Gerasimov. (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263-272.
7. Owen M and AJ Friedenstein. (1988). Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136:42-60.
8. Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641-650.
9. Pittenger MF. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
10. Covas DT, JLC Siufi, ARL Silva and MD Orellana. (2003). Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 36:1179-1183.
11. Covas DT, CE Piccinato, MD Orellana, JLC Siufi, WA Silva, R Proto-Siqueira, EG Rizzatti, L Neder, ARL Silva, V Rocha and MA Zago. (2005). Mesenchymal stem cells can be obtained from the human saphena vein. Exp Cell Res 309:340-344.
12. Nöth U, AM Osyczka, R Tuli, NJ Hickok, KG Danielson and RS Tuan. (2002). Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20:1060-1069.
13. Tuan RS, G Boland and R Tuli. (2003). Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5:32-45.
14. Gimble J and F Guilak. (2003). Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5:362-369.
15. Barlow S, G Brooke, K Chatterjee, G Price, R Pelekanos, T Rossetti, M Doody, D Venter, S Pain, K Gilshenan and K Atkinson. (2008). Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17:1095-1107.
16. Boxall SA and E Jones. (2012). Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012:1-12.
17. Mabuchi Y and Y Matsuzaki. (2016). Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs. Int J Hematol 103:138-144.
18. Bühring H-J, S Treml, F Cerabona, P de Zwart, L Kanz and M Sobiesiak. (2009). Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann N Y Acad Sci 1176:124-134.
19. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
20. Tormin A, O Li, JC Brune, SWalsh, B Schütz,MEhinger, N Ditzel,MKassemand S Scheding. (2011). CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117:5067-5077.
21. Haniffa MA, MP Collin, CD Buckley and F Dazzi. (2009). Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 94:258-263.
22. Covas DT, RA Panepucci, AM Fontes, WA Silva, MD Orellana, MCC Freitas, L Neder, ARD Santos, LC Peres, MC Jamur and MA Zago. (2008). Multipotent mesenchymal stromal cells obtained fromdiverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 36:642-654.
23. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating. (2005). Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7:393-395.
24. Bianco P, PG Robey and PJ Simmons. (2008). Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313-319.
25. Sacchetti B, A Funari, S Michienzi, S Di Cesare, S Piersanti, I Saggio, E Tagliafico, S Ferrari, PG Robey, M Riminucci and P Bianco. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
26. Méndez-Ferrer S, TV Michurina, F Ferraro, AR Mazloom, BD Macarthur, SA Lira, DT Scadden, A Ma'ayan, GN Enikolopov and PS Frenette. (2010). Mesenchymal and haematopoietic stem cells form a unique bonemarrow niche. Nature 466:829-834.
27. Hennig T, H Lorenz, A Thiel, K Goetzke, A Dickhut, F Geiger and W Richter. (2007). Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFb receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211:682-691.
28. Brocher J, P Janicki, P Voltz, E Seebach, E Neumann, U Mueller-Ladner and W Richter. (2013). Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: rescue by chondrogenic pre-induction. Stem Cell Res 11:1393-1406.
29. Hsiao ST, A Asgari, Z Lokmic, R Sinclair, GJ Dusting, SY Lim and RJ Dilley. (2012). Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev 21:2189-2203.
30. Jansen BJH, C Gilissen, H Roelofs, A Schaap-Oziemlak, JA Veltman, RA Raymakers, JH Jansen, G Kögler, CG Figdor, R Torensma and GJ Adema. (2010). Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 19:481-490.
31. Shi S and S Gronthos. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704.
32. Gronthos S, ACW Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis and PJ Simmons. (2003). Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
33. Tintut Y, Z Alfonso, T Saini, K Radcliff, K Watson, K Boström and LL Demer. (2003). Multilineage potential of cells from the artery wall. Circulation 108:2505-2510.
34. da Silva Meirelles L, PC Chagastelles and NB Nardi. (2006). Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 119:2204-2213.
35. Krautler NJ, V Kana, J Kranich, Y Tian, D Perera, D Lemm, P Schwarz, A Armulik, JL Browning, et al. (2012). Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150:194-206.
36. Aguzzi A, J Kranich and NJ Krautler. (2014). Follicular dendritic cells: origin, phenotype, and function in health and disease. Trends Immunol 35:105-113.
37. Kostallari E, Y Baba-Amer, S Alonso-Martin, P Ngoh, F Relaix, P Lafuste and RK Gherardi. (2015). Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence. Development 142: 1242-1253.
38. Crisan M, S Yap, L Casteilla, C-W Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
39. Caplan AI. (2008). All MSCs are pericytes? Cell Stem Cell 3:229-230.
40. Rouget C. (1873). Memoire sur le developpement, la structures et les proprietes des capillaires sanguins et lymphatiques. Archs Physiol Norm Pathol 5:603-633.
41. Sims DE. (1986). The pericyte-a review. Tissue Cell 18:153-174.
42. Armulik A, G Genové and C Betsholtz. (2011). Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193-215.
43. D?áz-Flores L, R Gutiérrez, JF Madrid, H Varela, F Valladares, E Acosta and P Mart?n-Vasallo. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 24:909-969.
44. Langhans TH. (1866). Beitrage zur normalen un pathologischen anatomie der arterien. Virch Arch 36:226.
45. Shchelkunov SI (1977). The main principles of cell differentiation. Academy of Medical Sciences of the USSR. Moscow: Medicine. 253 pages. [in Russian].
46. Andreeva ER, IMPugach,DGordon andANOrekhov. (1998). Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 30:127-135.
47. Zannettino ACW, S Paton, A Arthur, F Khor, S Itescu, JM Gimble and S Gronthos. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214:413-421.
48. Grcevic D, S Pejda, BG Matthews, D Repic, L Wang, H Li, MS Kronenberg, X Jiang, P Maye, et al. (2012). In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 30:187-196.
49. Nehls V and D Drenckhahn. (1993). The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry 99:1-12.
50. Tang W, D Zeve, JM Suh, D Bosnakovski, M Kyba, RE Hammer, MD Tallquist and JM Graff. (2008). White fat progenitor cells reside in the adipose vasculature. Science 322:583-586.
51. Olson LE and P Soriano. (2011). PDGFRb signaling regulates mural cell plasticity and inhibits fat development. Dev Cell 20:815-826.
52. Heldin CH and B Westermark. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316.
53. Nehls V, K Denzer and D Drenckhahn. (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469-474.
54. Neng L, W Zhang, A Hassan, M Zemla, A Kachelmeier, A Fridberger, M Auer and X Shi. (2013). Isolation and culture of endothelial cells, pericytes and perivascular resident macrophage-like melanocytes from the young mouse ear. Nat Protoc 8:709-720.
55. Hellström M, M Kalén, P Lindahl, A Abramsson and C Betsholtz. (1999). Role of PDGF-B and PDGFR-b in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047-3055.
56. Anjos-Afonso F, EK Siapati and D Bonnet. (2004). In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655-5664.
57. Chan J, K O'Donoghue, M Gavina, Y Torrente, N Kennea, H Mehmet, H Stewart, DJ Watt, JE Morgan and NM Fisk. (2006). Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24:1879-1891.
58. Burlacu A, A-M Rosca, H Maniu, I Titorencu, E Dragan, V Jinga and M Simionescu. (2008). Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur J Cell Biol 87:173-184.
59. Moreno PR, KR Purushothaman, E Zias, J Sanz and V Fuster. (2006). Neovascularization in human atherosclerosis. Curr Mol Med 6:457-477.
60. Lin G, M Garcia, H Ning, L Banie, Y-L Guo, TF Lue and C-S Lin. (2008). Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17:1053-1063.
61. Hu Y, Z Zhang, E Torsney, AR Afzal, F Davison, B Metzler and Q Xu. (2004). Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113:1258-1265.
62. Hu Y and Q Xu. (2011). Adventitial biology: differentiation and function. Arterioscler Thromb Vasc Biol 31:1523-1529.
63. Hoshino A, H Chiba, K Nagai, G Ishii and A Ochiai. (2008). Human vascular adventitial fibroblasts contain mesenchymal stem/progenitor cells. Biochem Biophys Res Commun 368: 305-310.
64. Mabuchi Y, S Morikawa, S Harada, K Niibe, S Suzuki, F Renault-Mihara, DD Houlihan, C Akazawa, H Okano and Y Matsuzaki. (2013). LNGFR+THY-1+VCAM-1hi+ cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Reports 1:152-165.
65. Pusztaszeri MP, W Seelentag and FT Bosman. (2006). Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385-395.
66. Zengin E, F Chalajour, UM Gehling, WD Ito, H Treede, H Lauke, J Weil, H Reichenspurner, N Kilic and S Ergün. (2006). Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133:1543-1551.
67. Corselli M, C-W Chen, B Sun, S Yap, JP Rubin and B Peaúlt. (2012). The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev 21:1299-1308.
68. HowsonKM,ACAplin,MGelati,GAlessandri,EAParati and RF Nicosia. (2005). The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol 289:C1396-C1407.
69. Zhao H, J Feng, K Seidel, S Shi, O Klein, P Sharpe and Y Chai. (2014). Secretion of shh by a neurovascular bundle niche supports mesenchymal stem cell homeostasis in the adult mouse incisor. Cell Stem Cell 14:160-173.
70. Cattoretti G, R Schiró, A Orazi, D Soligo and MP Colombo. (1993). Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 81:1726-1738.
71. Zhang J, C Niu, L Ye, H Huang, X He, W-G Tong, J Ross, J Haug, T Johnson, et al. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-841.
72. Qian H, A Badaloni, F Chiara, J Stjernberg, N Polisetti, K Nihlberg, GG Consalez and M Sigvardsson. (2013). Molecular characterization of prospectively isolated multipotent mesenchymal progenitors provides new insight into the cellular identity of mesenchymal stem cells in mouse bone marrow. Mol Cell Biol 33:661-677.
73. Kieslinger M, S Folberth, G Dobreva, T Dorn, L Croci, R Erben, GG Consalez and R Grosschedl. (2005). EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev Cell 9:757-767.
74. Chan CKF, EY Seo, JY Chen, D Lo, A McArdle, R Sinha, R Tevlin, J Seita, J Vincent-Tompkins, et al. (2015). Identification and specification of the mouse skeletal stem cell. Cell 160:285-298.
75. Ueno H and IL Weissman. (2006). Clonal analysis of mouse development reveals a polyclonal origin for yolk sac blood Islands. Dev Cell 11:519-533.
76. Worthley DL, M Churchill, JT Compton, Y Tailor, M Rao, Y Si, D Levin, MG Schwartz, A Uygur, et al. (2015). Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell 160:269-284.
77. Kassem M and P Bianco. (2015). Skeletal stem cells in space and time. Cell 160:17-19.
78. Thiery JP, H Acloque, RYJ Huang and MA Nieto. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
79. Potenta S, E Zeisberg and R Kalluri. (2008). The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99:1375-1379.
80. Pla P, RMoore, OGMorali, S Grille, SMartinozzi, V Delmas and L Larue. (2001). Cadherins in neural crest cell development and transformation. J Cell Physiol 189:121-132.
81. Kovacic JC, N Mercader, M Torres, M Boehm and V Fuster. (2012). Epithelial-to-mesenchymal and endothelialto-mesenchymal transition: from cardiovascular development to disease. Circulation 125:1795-1808.
82. Thiery JP. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
83. Zeisberg EM, O Tarnavski, M Zeisberg, AL Dorfman, JR McMullen, E Gustafsson, A Chandraker, X Yuan, WT Pu, et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952-961.
84. Zeisberg EM, S Potenta, L Xie, M Zeisberg and R Kalluri. (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67:10123-10128.
85. Mani SA, W Guo, MJ Liao, EN Eaton, A Ayyanan, AY Zhou, M Brooks, F Reinhard, CC Zhang, et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
86. Battula VL, KW Evans, BG Hollier, Y Shi, FC Marini, A Ayyanan, R-Y Wang, C Brisken, R Guerra, M Andreeff and SA Mani. (2010). Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28:1435-1445.
87. Phinney DG. (2011). Twist, epithelial-to-mesenchymal transition, and stem cells. Stem Cells 29:3-4.
88. Isenmann S, A Arthur, ACW Zannettino, JL Turner, S Shi, CA Glackin and S Gronthos. (2009). TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27:2457-2468.
89. Medici D, EM Shore, VY Lounev, FS Kaplan, R Kalluri and BR Olsen. (2010). Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16:1400-1406.
90. Caplan AI and D Correa. (2011). The MSC: an injury drugstore. Cell Stem Cell 9:11-15.
91. Chong JJH, V Chandrakanthan, M Xaymardan, NS Asli, J Li, I Ahmed, C Heffernan, MK Menon, CJ Scarlett, et al. (2011). Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9:527-540.
92. Birbrair A, T Zhang, Z-M Wang, ML Messi, GN Enikolopov, A Mintz and O Delbono. (2013). Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev 22:2298-2314.
93. Ieronimakis N, AL Hays, K Janebodin, WM Mahoney, JS Duffield, MW Majesky and M Reyes. (2013). Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFb1 signaling in the mdx mouse model of Duchenne muscular dystrophy. J Mol Cell Cardiol 63:122-134.
94. Winkler EA, RD Bell and B V Zlokovic. (2010). Pericytespecific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener 5:32.
95. Seifert RA, CE Alpers and DF Bowen-Pope. (1998). Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int 54:731-746.
96. Dore-Duffy P, A Katychev, X Wang and E Van Buren. (2006). CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 26:613-624.
97. Pinho S, J Lacombe, M Hanoun, T Mizoguchi, I Bruns, Y Kunisaki and PS Frenette. (2013). PDGFRa and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J Exp Med 210:1351-1367.
98. Reis-Filho JS, D Steele, S Di Palma, RL Jones, K Savage, M James, F Milanezi, FC Schmitt and A Ashworth. (2006). Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol 19:307-319.
99. Berry R and MS Rodeheffer. (2013). Characterization of the adipocyte cellular lineage in vivo. Nat Cell Biol 15:302-308.